S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
MarketBeat Week in Review – 1/30 - 2/3
A gold storm is coming… (Ad)
Skull found in '97 in remote Alaska belongs to New York man
Jury: Musk didn't defraud investors with 2018 Tesla tweets
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Why a new Alzheimer's drug is having a slow US debut
State of the Union: Biden sees economic glow, GOP sees gloom
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
New California oil well ban put on hold for voters to decide
Sri Lanka marks independence anniversary amid economic woes
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
MarketBeat Week in Review – 1/30 - 2/3
A gold storm is coming… (Ad)
Skull found in '97 in remote Alaska belongs to New York man
Jury: Musk didn't defraud investors with 2018 Tesla tweets
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Why a new Alzheimer's drug is having a slow US debut
State of the Union: Biden sees economic glow, GOP sees gloom
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
New California oil well ban put on hold for voters to decide
Sri Lanka marks independence anniversary amid economic woes
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
MarketBeat Week in Review – 1/30 - 2/3
A gold storm is coming… (Ad)
Skull found in '97 in remote Alaska belongs to New York man
Jury: Musk didn't defraud investors with 2018 Tesla tweets
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Why a new Alzheimer's drug is having a slow US debut
State of the Union: Biden sees economic glow, GOP sees gloom
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
New California oil well ban put on hold for voters to decide
Sri Lanka marks independence anniversary amid economic woes
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
MarketBeat Week in Review – 1/30 - 2/3
A gold storm is coming… (Ad)
Skull found in '97 in remote Alaska belongs to New York man
Jury: Musk didn't defraud investors with 2018 Tesla tweets
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Why a new Alzheimer's drug is having a slow US debut
State of the Union: Biden sees economic glow, GOP sees gloom
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
New California oil well ban put on hold for voters to decide
Sri Lanka marks independence anniversary amid economic woes
NYSE:MCK

McKesson - MCK Stock Forecast, Price & News

$362.58
-3.90 (-1.06%)
(As of 02/3/2023 12:00 AM ET)
Add
Compare
Today's Range
$361.54
$373.03
50-Day Range
$362.58
$386.85
52-Week Range
$260.73
$401.78
Volume
1.32 million shs
Average Volume
995,103 shs
Market Capitalization
$51.41 billion
P/E Ratio
16.58
Dividend Yield
0.59%
Price Target
$416.30

McKesson MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.78 Rating Score
Upside/​Downside
14.8% Upside
$416.30 Price Target
Short Interest
Healthy
2.49% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-1.01
Upright™ Environmental Score
News Sentiment
0.31mentions of McKesson in the last 14 days
Based on 21 Articles This Week
Insider Trading
Selling Shares
$6.13 M Sold Last Quarter
Proj. Earnings Growth
3.79%
From $25.57 to $26.54 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.77 out of 5 stars

Medical Sector

43rd out of 1,028 stocks

Drugs, Proprietaries, & Sundries Industry

3rd out of 6 stocks

MCK stock logo

About McKesson (NYSE:MCK) Stock

McKesson Corp. engages in the provision of supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. It operates through the following segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products, provides practice management, technology, clinical support, and business solutions to community-based oncology, and other specialty practices, and sells financial, operational, and clinical solutions to pharmacies and provides consulting, outsourcing, technological, and other services. The International segment provides distribution and services to wholesale, institutional, and retail customers in European countries and Canada. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The RxTS segment br

Receive MCK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for McKesson and its competitors with MarketBeat's FREE daily newsletter.

MCK Stock News Headlines

A gold storm is coming…
“We are in the early stages of a mania – the calm before the storm.”...
UBS Group Lowers McKesson (NYSE:MCK) Price Target to $440.00
McKesson (MCK) Q3 2023 Earnings Call Transcript
McKesson (MCK) Tops Q3 Earnings and Revenue Estimates
A gold storm is coming…
“We are in the early stages of a mania – the calm before the storm.”...
McKesson updated 2023 guidance boosts non-GAAP EPS
2 Medical Stocks to Consider Buying Before Earnings
McKesson (MCK) Set to Announce Quarterly Earnings on Wednesday
ResMed's (RMD) Q2 Earnings Beat Estimates, Margins Falls
McKesson (MCK) Stock Moves -1.32%: What You Should Know
4 Stocks You Should Be Eager to Buy in 2023
McKesson (MCK) Flat As Market Sinks: What You Should Know
Boring Was King of Healthcare in 2022
See More Headlines
Receive MCK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for McKesson and its competitors with MarketBeat's FREE daily newsletter.

MCK Company Calendar

Ex-Dividend for 1/3 Dividend
11/30/2022
Dividend Payable
1/03/2023
Last Earnings
2/01/2023
Today
2/04/2023
Ex-Dividend for 4/3 Dividend
2/28/2023
Fiscal Year End
3/31/2023
Dividend Payable
4/03/2023
Next Earnings (Estimated)
5/04/2023

Industry, Sector and Symbol

Industry
Drugs, proprietaries, & sundries
Sub-Industry
Health Care Distributors
Sector
Medical
CUSIP
58155Q10
Employees
75,000
Year Founded
1833

Price Target and Rating

Average Stock Price Forecast
$416.30
High Stock Price Forecast
$450.00
Low Stock Price Forecast
$376.00
Forecasted Upside/Downside
+14.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.78
Research Coverage
9 Analysts

Profitability

Net Income
$1.11 billion
Pretax Margin
1.59%

Debt

Sales & Book Value

Annual Sales
$263.97 billion
Cash Flow
$31.23 per share
Book Value
($14.73) per share

Miscellaneous

Free Float
141,495,000
Market Cap
$51.41 billion
Optionable
Optionable
Beta
0.61

Social Links


Key Executives

  • Brian Scott TylerBrian Scott Tyler
    Chief Executive Officer & Director
  • Britt J. VitaloneBritt J. Vitalone
    Chief Financial Officer & Executive Vice President
  • Nancy FloresNancy Flores
    Chief Technology & Information Officer, EVP
  • Maria Teresa Lensing
    Chief Technology Officer-Engineering & SVP
  • Lori A. SchechterLori A. Schechter
    Chief Legal Officer, EVP & General Counsel













MCK Stock - Frequently Asked Questions

Should I buy or sell McKesson stock right now?

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for McKesson in the last year. There are currently 2 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" MCK shares.
View MCK analyst ratings
or view top-rated stocks.

What is McKesson's stock price forecast for 2023?

9 brokerages have issued 12-month price objectives for McKesson's stock. Their MCK share price forecasts range from $376.00 to $450.00. On average, they anticipate the company's stock price to reach $416.30 in the next year. This suggests a possible upside of 14.8% from the stock's current price.
View analysts price targets for MCK
or view top-rated stocks among Wall Street analysts.

How have MCK shares performed in 2023?

McKesson's stock was trading at $375.12 at the beginning of the year. Since then, MCK shares have decreased by 3.3% and is now trading at $362.58.
View the best growth stocks for 2023 here
.

Are investors shorting McKesson?

McKesson saw a drop in short interest in January. As of January 15th, there was short interest totaling 3,520,000 shares, a drop of 8.8% from the December 31st total of 3,860,000 shares. Based on an average daily volume of 1,070,000 shares, the short-interest ratio is currently 3.3 days. Approximately 2.5% of the shares of the stock are sold short.
View McKesson's Short Interest
.

When is McKesson's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 4th 2023.
View our MCK earnings forecast
.

How were McKesson's earnings last quarter?

McKesson Co. (NYSE:MCK) announced its quarterly earnings results on Wednesday, February, 1st. The company reported $6.90 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.36 by $0.54. The firm had revenue of $70.49 billion for the quarter, compared to the consensus estimate of $70.98 billion. McKesson had a negative trailing twelve-month return on equity of 216.12% and a net margin of 1.15%. The company's quarterly revenue was up 2.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned $6.15 earnings per share.
Read the conference call transcript
.

How often does McKesson pay dividends? What is the dividend yield for McKesson?

McKesson announced a quarterly dividend on Thursday, January 26th. Investors of record on Wednesday, March 1st will be paid a dividend of $0.54 per share on Monday, April 3rd. This represents a $2.16 dividend on an annualized basis and a yield of 0.60%. The ex-dividend date of this dividend is Tuesday, February 28th.
Read our dividend analysis for MCK
.

Is McKesson a good dividend stock?

McKesson (NYSE:MCK) pays an annual dividend of $2.16 per share and currently has a dividend yield of 0.59%. The company has been increasing its dividend for 15 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 9.88%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, MCK will have a dividend payout ratio of 8.14% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for MCK.

What guidance has McKesson issued on next quarter's earnings?

McKesson issued an update on its FY23 earnings guidance on Wednesday, February, 1st. The company provided EPS guidance of $25.75-26.15 for the period, compared to the consensus EPS estimate of $24.80.

What is Brian Tyler's approval rating as McKesson's CEO?

220 employees have rated McKesson Chief Executive Officer Brian Tyler on Glassdoor.com. Brian Tyler has an approval rating of 88% among the company's employees.

What other stocks do shareholders of McKesson own?

Based on aggregate information from My MarketBeat watchlists, some companies that other McKesson investors own include Walt Disney (DIS), Johnson & Johnson (JNJ), Gilead Sciences (GILD), CVS Health (CVS), AbbVie (ABBV), Bank of America (BAC), AT&T (T), JPMorgan Chase & Co. (JPM), UnitedHealth Group (UNH) and Home Depot (HD).

What is McKesson's stock symbol?

McKesson trades on the New York Stock Exchange (NYSE) under the ticker symbol "MCK."

Who are McKesson's major shareholders?

McKesson's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Pzena Investment Management LLC (0.69%), Sumitomo Mitsui Trust Holdings Inc. (0.30%), New York State Common Retirement Fund (0.24%), Strs Ohio (0.22%), Artemis Investment Management LLP (0.16%) and Natixis Advisors L.P. (0.16%). Insiders that own company stock include Brian S Tyler, Brian S Tyler, Britt J Vitalone, Kevin Emerson, Lori A Schechter, Lori A Schechter, Marie L/Ca Knowles, Nancy Flores, Sundeep G Reddy, Sundeep G Reddy, Thomas L Rodgers, Thomas L Rodgers and Tracy Faber.
View institutional ownership trends
.

How do I buy shares of McKesson?

Shares of MCK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is McKesson's stock price today?

One share of MCK stock can currently be purchased for approximately $362.58.

How much money does McKesson make?

McKesson (NYSE:MCK) has a market capitalization of $51.41 billion and generates $263.97 billion in revenue each year. The company earns $1.11 billion in net income (profit) each year or $21.87 on an earnings per share basis.

How many employees does McKesson have?

The company employs 75,000 workers across the globe.

Does McKesson have any subsidiaries?
The following companies are subsidiares of McKesson: A.L.I. Technologies, AMISYS Managed Care Systems, Abaton.com, Access Health, Biologics, Celesio, CoverMyMeds, D & K Healthcare Resources, Drug Trading Co. Ltd., EN-Chart Scanning Program, Echo, Emendo, Enterprise Systems Inc., HBO & Company, HPR, HealthCom Partners, HealthQx, IMNET Systems, LloydsDirect, MED3000, McKesson Europe AG, McKesson Europe Holdings GmbH & Co. KGaA, McKesson Global Procurement & Sourcing Limited, McKesson International Bermuda IP2A Limited, McKesson International Bermuda IP3A Limited, McKesson Ireland Limited, McKesson Medical-Surgical Holdings Inc., McKesson Medical-Surgical Inc., McKesson Medical-Surgical Supply Chain Services LLP, McKesson Medical-Surgical Top Holdings Inc., McKesson Plasma and Biologics LLC, McKesson Specialty Care Distribution LLC, McKesson UK Finance I Limited, McKesson UK Finance II Limited, McKesson US Finance Corporation, McQueary Brothers, MedVentive, Medcon, MediVation Inc., Medical Specialties Distributors, Medis Health And Pharmaceutical Services, Moore Medical, NDCHealth, Oncology Therapeutics Network, PSS World Medical, Per-Se Technologies, Portico Systems, Practice Partner, RedLine HealthCare, RelayHealth, Rexall, Rosebud Solutions, RxCrossroads, Sterling Medical Services LLC, UDG Healthcare, US Oncology, US Oncology Holdings Inc., US Oncology Inc., United Drug (Wholesale) Limited, United Drug Distributors Ireland Limited, Vantage Oncology, Vivalog Technologies, Well.ca, and peerVue.
Read More
How can I contact McKesson?

McKesson's mailing address is 6555 STATE HWY 161, IRVING TX, 75039. The official website for the company is www.mckesson.com. The company can be reached via phone at (972) 446-4800, via email at investors@mckesson.com, or via fax at 415-983-8453.

This page (NYSE:MCK) was last updated on 2/4/2023 by MarketBeat.com Staff